For more information, visit our Kidney Tumor Program
Return to Cancer Program Name Search
Title: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
Brief Title: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
Brief Summary: CyberKnife Based Radiosurgery is a way to deliver large doses of radiation very
accurately to a tumor. The ability of this technology to minimize radiation dose to
organs adjacent to the target tumor allows a high dose to be delivered to the tumor, thus
potentially increasing the efficacy of radiation treatment. Currently, radiosurgery is
commonly used for brain metastases, Stage I lung cancer, spine tumors, and localized
prostate cancer. The purpose of this protocol is to evaluate the role of Radiosurgery for
the treatment of clinically localized primary renal cell carcinoma.
For info regarding 12-235
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Collection of Specimen and Clinical Data from Patients with Renal Cell Carcinoma
Brief Title: COLLECTION OF SPECIMENS FROM PATIENTS WITH RENAL CELL
For info regarding 01-130
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu